Posted by Clinical Lab Products | Oct 1, 2009 | Cancer, Miscellaneous |
Coriell Institute for Medical Research announces that Ohio State University Medical Center will join the Coriell Personalized Medicine Collaborative research study and examine the utility of incorporating genome information into patients primary healthcare at the medical center.
Read MorePosted by Clinical Lab Products | May 28, 2009 | Cancer, Miscellaneous |
A study led by researchers at Fred Hutchinson Cancer Research Center has identified two proteins in the blood that could become important prognostic markers for long-term survival in breast cancer patients.
Read MorePosted by Clinical Lab Products | Apr 30, 2009 | Cancer, Miscellaneous, Tissue Processing |
Many studies determine hormone levels in the blood as a marker of breast cancer risk. But it hasnt been known whether these blood tests reflect what is happening in the breast tissue, where certain hormones fuel cancer.
Read MorePosted by Clinical Lab Products | Mar 27, 2009 | Biochemicals & Chemical Reagents, Cancer, Unknown Origin & Other Cancer Types |
BioMosaics Inc, a cancer biomarker development company, announced today that its monoclonal antibody product (clone 1G12) for detection of Glypican-3 (GPC3) has been validated for use as an immunohistochemical test for diagnosis of Hepatocellular Carcinoma (HCC).
Read MorePosted by Clinical Lab Products | Mar 9, 2009 | Miscellaneous |
B-R-A-H-M-S Aktiengesellschaft announces that it has submitted 510(k) file to the FDA to market its patented B-R-A-H-M-S MR-proANP Kryptor Test.
Read More